KARA SIERRA: Open Payments
NPI 1568820389 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,793 in 121 payments from 17 companies in 2025. Trend: 2023 $1,797 · 2024 $1,622 · 2025 $1,793
Food & beverage: $1,793
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $407 |
| Janssen Biotech, Inc. | 17 | $322 |
| Gilead Sciences, Inc. | 6 | $172 |
| Aimmune Therapeutics, Inc. | 15 | $161 |
| Phathom Pharmaceuticals, Inc. | 20 | $153 |
| Madrigal Pharmaceuticals | 7 | $142 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $93 |
| QOL Medical, LLC | 3 | $52 |
| Regeneron Healthcare Solutions, Inc. | 2 | $51 |
| Lilly USA, LLC | 3 | $50 |
Products named: TREMFYA, RINVOQ, ZENPEP, VOQUEZNA, LINZESS, REZDIFFRA, XIFAXAN, CREON.
Industry payments across AR — which companies pay providers there.
